Literature DB >> 10570102

The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.

M Hueso1, J Bover, D Serón, S Gil-Vernet, G Rufí, J Alsina, J M Grinyó.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10570102     DOI： 10.1093/ndt/14.12.2941

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

Review 1.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

2.  Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs.

Authors:  Nishi Shakya; Preeti Bajpai; Suman Gupta
Journal:  J Parasit Dis       Date:  2011-05-20

Review 3.  Therapeutic options for visceral leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

4.  Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole.

Authors:  Soumaya Yaich; Khaled Charfeddine; Abderrahmen Masmoudi; Mondher Masmoudi; Sawssen Zaghdhane; Hamida Turki; Jamil Hachicha
Journal:  Ann Saudi Med       Date:  2012-07-01       Impact factor: 1.526
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.